Jinwon Life Sciences and Ildong Pharmaceutical’s stock prices are rising due to monkeypox.
According to the Korea Exchange on the 3rd, Jinwon Life Sciences and Ildong Pharmaceutical are trading at 12,500 won, up 150 won (1.21%) from the previous trading day, and 44,450 won, up 450 won (1.02%) as of 9:54 a.m. on the same day.
The European Medicines Agency (EMA) announced on the 2nd (local time) that it is discussing with manufacturers how to use the vaccine used for smallpox as a vaccine against monkeypox.
EMA’s vaccine strategy director, Macro Cavaleri, said, “We are discussing whether the smallpox vaccine ‘Imbanex’ can be used if necessary for prevention,” AFP news agency reported.
Developed by Danish company Bavarian Nordic, Imbanex was approved as a smallpox vaccine in Europe in 2013, but in the United States it was approved for use in the prevention of monkeypox and alleviation of serious injuries.
If approval is granted for Imbanex to be used for the prevention of monkeypox, it is highly likely that people who have come into contact with someone infected with monkeypox will be vaccinated.
© ‘Global Economic Daily in 5 Languages’ Ajou Economic Daily. Unauthorized reproduction and redistribution prohibited